Biotricity Inc. (BTCY) vs Co-Diagnostics, Inc. (CODX)
Biotricity Inc. and Co-Diagnostics, Inc. are both Medical Devices companies. Biotricity Inc. is the larger, with a market value of $10.9M against $8.3M — 1.3× the size. Biotricity Inc. grew revenue faster over the last twelve months: 13.4% against −28.1%. Biotricity Inc. has the higher net margin (−21.0% vs −6,522.9%) and the higher return on invested capital (0.00% vs −337.7%). Across the 17 metrics below, Biotricity Inc. leads on 14 and Co-Diagnostics, Inc. on 3.
Valuation
Profitability
| Metric | BTCY | CODX | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.47% | 43.47% | 56.01% |
| Operating margin | 9.56% | (6,787.47%) | (15.03%) |
| Net margin | (21.00%) | (6,522.91%) | (20.40%) |
| Free cash flow margin | 0.99% | (3,807.94%) | (7.24%) |
| Return on equity | 9.75% | (174.77%) | (15.32%) |
| Return on assets | (57.12%) | (149.25%) | (19.72%) |
| Return on invested capital | 0.00% | (337.68%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack